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Abstract
Skeletal muscle is described as an endocrine organ, constitutively or intermit-
tently secreting bioactive molecules. The signaling pathways by which these
molecules mediate changes in skeletal muscle and regulate interorgan crosstalk
are only partly understood. Lactate is widely described as a signaling molecule
in different cells, but the role of lactate as a signaling molecule in mature
skeletal muscle has not been fully unveiled. The aim of this study was to
determine the role of lactate on activation of signaling pathways in adult
mouse skeletal muscle. Male mice were injected intraperitoneally with lactate
or saline, and tissues were dissected after 40 min. Phosphorylation levels of
relevant proteins in muscle were assessed by Western blotting. After lactate
administration, we found an increase in p-ERK1/2Thr202/Tyr204 (3.5-fold;
P = 0.004) and p-p70S6KThr389 (1.9-fold; P = 0.01) in quadriceps; and an
increase in p-rpS6Ser235/236 in both quadriceps (6.3-fold; P = 0.01) and EDL
(2.3-fold; P = 0.01), without changes in soleus. There was a tendency toward
an increase in p-AMPKThr172 (1.7-fold; P = 0.08), with a significant increase
in p-ACCSer79 (1.5-fold; P = 0.04) in soleus, without changes in quadriceps
and EDL. These results support the hypothesis that lactate plays a role in the
molecular signaling related to hypertrophy and to oxidative metabolism on
adult skeletal muscle and suggest that this activation depends on the skeletal
muscle type. The mechanisms that underlie the effect of lactate in mature
skeletal muscles remain to be established.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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Introduction
Skeletal muscle represents ~40% of body weight and is
integral for locomotion and metabolic health (Brook et al.
2016). Recent years have provided clear evidence for
skeletal muscle being an endocrine organ, constitutively
or intermittently secreting bioactive molecules (Weigert
et al. 2014). The biologically active molecules released
from skeletal muscle cells during muscle contraction exert
autocrine, paracrine, and endocrine effects (Pedersen
2011; Pillon et al. 2012). The discovery of how these
molecules mediate changes in skeletal muscle and regulate
interorgan crosstalk could reveal novel therapeutic targets
and support the development of personalized exercise
training regimens.
Historically, lactate has often been incorrectly viewed
as a dead-end, fatigue-causing waste product (Ferguson
et al. 2018). Currently, the cell-to-cell lactate shuttle
supports a role of lactate as an oxidative and gluco-
neogenic substrates (Brooks 2018). In skeletal muscle,
lactate is converted to pyruvate in the cytosol, and is
then used as a source of carbon for the tricarboxylic
acid cycle (Hui et al. 2017). Recently, lactate has been
described as a signaling molecule in adipocytes (Liu
et al. 2009), astrocytes (Yang et al. 2014), liver (Lezi
et al. 2013), and capillaries (Morland et al. 2017). In
vivo lactate administration increases messenger RNA
levels of oxidative metabolism-related genes as PGC-1a
in skeletal muscle of mouse (Kitaoka et al. 2016). In
skeletal muscle cell lines as L6 and C2C12, lactate acti-
vates the ERK1/2 pathway (Li et al. 2014) and is also
related to both oxidative metabolism (Hashimoto et al.
2007; Kim et al. 2017), and hypertrophy signaling
(Ohno et al. 2018; Oishi et al. 2015). However, the
molecular signaling activated by lactate in mature skele-
tal muscle has not been fully unveiled.
We hypothesized that lactate plays a role in the molec-
ular signaling related to hypertrophy and to oxidative
metabolism in adult skeletal muscle. To test this hypothe-
sis, we exposed mice to in vivo lactate administration and
analyzed intracellular signaling activation in adult skeletal
muscle.
Methods
Ethical approval
All experiments as well as the breeding protocol per-
formed in Denmark were approved by the Danish
Animal Experimental Inspectorate and complied with
the European Convention for the Protection of Verte-
brate Animals used for Experiments and other Scien-
tific Purposes (authorization 2015-15-0201-00477). The
Bioethics Committee of the Faculty of Medicine,
Universidad de Chile, approved all animal procedures
performed in Chile (authorization CBA-0822-FMUCH).
The experiments to assess phosphorylation of proteins
were performed in Denmark, and the experiments to
assess insulin and glucose levels were performed in
Chile.
Animals
Male mice were maintained on a 12:12 light-dark cycle
with unlimited access to standard rodent chow and
water. Animals (C57BL/6JRj) for the experiment per-
formed in Denmark were obtained from Janvier Labs
(Le Genest St. Isle, France). The animals (C57BL/6J)
for the experiment performed in Chile were obtained
from the Animal Facility at the Faculty of Medicine
(Universidad de Chile).
Lactate administration
All mice were 10–12 weeks old at the start of the
experiments. On the day of the experiment, mice were
transferred to individual cages and were fasted for 5–
6 h. Mice were anesthetized (6 mg pentobarbital
sodium and 0.6 mg lidocaine /100 g body weight (Jen-
sen et al. 2015)) and randomly assigned to either vehi-
cle group (VEH) or lactate group (LAC). LAC mice
received an intraperitoneal injection (IP) of sodium
L-lactate (≥99.0%, Aldrich, 71718; 3 g/kg body weight;
dissolved in phosphate buffered saline; pH-adjusted to
7.4). VEH mice received the same volume (per kg
bodyweight) of phosphate-buffered saline (sodium phos-
phate monobasic (Aldrich, S3139; 1.7 mmol/L); sodium
phosphate dibasic (Merck, 567550; 8.1 mmol/L); sodium
chloride (Aldrich, S5886; 147 mmol/L); pH 7.4). The
dose of lactate was chosen from previous experiments
to obtain values of blood lactate about 20 mmol/L,
which are similar to those found after maximal exercise
(Juel et al. 1990). Gross estimation of blood sodium
and effective osmolality values after the sodium lactate
injection suggest that values were within a normal
range of variation in mice (Bekkevold et al. 2013; Otto
et al. 2016).
Blood lactate, glucose, and insulin
measurements
Blood samples were obtained from the tail before and
after lactate or vehicle administration. Basal blood lac-
tate, glucose, and insulin levels (0 min) were measured
before the IP injection. Lactate levels were measured 5,
15, and 30 min after the injection using a portable
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blood lactate analyzer (Lactate Plus, Nova Biomedical).
Glucose levels were measured 15 and 30 min after the
injection using a portable blood glucose analyzer (Free-
Style Optium, Abbott Diabetes Care). Submandibular
bleeding method (Golde et al. 2005) was used for blood
collection and to determine serum insulin concentra-
tions at 15 and 30 min after the injection using a com-
mercially available immunoassay specific for mice
(Millipore). The quadriceps (Quad), extensor digitorum
longus (EDL), and soleus (Sol) muscles were dissected
at 40 min after lactate administration, immediately
snap-frozen, and stored at 80°C. The interval between
snap-freezing and assaying for phosphorylation of pro-
teins was 1–2 days.
Muscle immunoblotting
For evaluation of total and phosphorylated levels of
proteins, lysates were prepared as previously described
(Jensen et al. 2015). Muscles from VEH (n = 5) and
LAC (n = 7) were homogenized in 300 lL ice-cold lysis
buffer (50 mmol/L TrisHCl, 150 mmol/L NaCl,
1 mmol/L EDTA, 1 mmol/L EGTA, 50 mmol/L NaF,
5 mmol/L Na4P2O7, 2 mmol/L Na3VO4, 1 mmol/L
dithiothreitol, 1 mmol/L benzamidine, 1% Nonidet
P-40, and 0.5% protease inhibitor cocktail, pH 7.4) on
a beadmill (Tissuelyzer II, Qiagen; 1 min, 30 Hz, maxi-
mum 10 muscles/round). Then, samples were rotated
end-over-end for 30 min at 4°C and spun at 13,000g
for 20 min to generate lysates. Protein determination
(1:10 dilution) was performed by Bicinchoninic acid
method (Pierce, Thermo Scientific) and lysates were sep-
arated on 10% SDS-PAGE gels. After electrophoresis,
proteins were transferred to polyvinylidene fluoride
membranes (Bio-Rad Laboratories). The primary anti-
bodies used were phospho-S6 Ribosomal Protein Ser235/
236 (Cell Signaling Technology (CST), USA, cat#4858),
phospho-Erk1/2 Thr202/Tyr204 (CST, cat#9101), phos-
pho-AMPKa Thr172 (CST, cat#2535), phospho-ACC
Ser79 (CST, cat#11818), AMPKa Total (CST, cat#5831),
phospho-Akt Thr308 (CST, cat#4056), phospho-Akt
Ser473 (CST, cat#9271), Akt2 Total (CST, cat#9272),
phospho-TBC1D1 Ser237 (Millipore, USA, cat#07-2268),
phospho-TBC1D4 Thr642 (CST, cat#8881), and phos-
pho-p70S6K Thr389 (CST, cat#9234). PDH-E1a phos-
phorylation at Ser293 and Ser300 were determined using
antibodies as previously described (Pilegaard et al.
2006). All blots were developed on a Chemidoc MP
imaging system (Bio-Rad Laboratories) using enhanced
chemiluminescence (ECL+, Amersham Biosciences). To
confirm equal loading of the samples, the blots were
submerged in Coomassie brilliant G-250 solution for
1 min (Moritz 2017), washed in distilled water and then
left in de-staining solution for 10–15 min before taking
a picture using the Chemidoc MP imaging system. Sig-
nals were quantified (Image Lab version 4.0, BioRad
Laboratories) and expressed as arbitrary units.
Statistical analysis
All values were expressed as median with interquartile
range (IQR). Nonparametric data were analyzed using
two-tailed Wilcoxon rank-sum test (also known as
Mann–Whitney). Statistical significance was set at
P < 0.05. As a complementary analysis, we assessed the
magnitude of the effect of the intervention via estima-
tion of the nonparametric effect size (ES; with 95%
confidence interval) (Ialongo 2016) according to formu-
las previously described (Ivarsson et al. 2013). The fol-
lowing threshold values for ES reported as d were
employed: <0.5 as small, 0.5–0.79 as medium, 0.8–1.29
as large, and ≥1.3 as very large (Ialongo 2016). Statisti-
cal analysis was performed using STATA 13.0 (Stata-
Corp, College Station, TX).
Results
Acute in vivo lactate administration
increases blood lactate levels
To study the effect of in vivo lactate stimulation,
anesthetized mice were lactate- or saline IP injected and
tissues were harvested 40 min post-injection. The time-
course of blood lactate after injection of lactate or vehicle
is shown in Figure 1A. Blood
lactate levels increased quickly after a single dose of lac-
tate, but not after injection of the same volume of phos-
phate
buffered saline. Lactate concentration peak was found
between 5 and 15 min after the
injection.
Acute in vivo lactate administration
increases blood lactate levels without
changes in neither blood glucose nor insulin
levels
Lactate is a gluconeogenic precursor in liver (Hui et al.
2017; van Hall 2010) and stimulates insulin secretion in
beta cell lines (Meats et al. 1989). To explore if lactate
induced an increase in blood glucose and insulin levels,
we measured glucose and insulin during in vivo lactate
administration. As represented in Figure 1, there were no
changes in blood glucose (Fig. 1B) or in insulin levels
(Fig. 1B) at any time in LAC group compared with the
VEH group.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Acute in vivo lactate administration induces
intracellular signaling in adult skeletal
muscle
Lactate activates MAPK pathways in skeletal myotubes
(Li et al. 2014). To test whether lactate activates the
ERK1/2 pathway in mature skeletal muscle, we measured
ERK1/2Thr202/Tyr204 phosphorylation 40 min after in vivo
lactate administration. As is shown in Fig. 2A, ERK1/
2Thr202/Tyr204 phosphorylation was increased by lactate in
Quad (3.5-fold; P = 0.004), without changes in EDL and
Sol.
Lactate is correlated with myotubes hypertrophy and
resistance training hypertrophy (Kawada and Ishii 2005;
Ohno et al. 2018; Oishi et al. 2015). To explore the effect
of lactate on anabolic pathways, we determined the acti-
vation of the canonical IGF-1/Akt/mTORC1 pathway. No
changes were observed in p-IGF-1RTyr1135/1136 (Fig. 2B).
Figure 2C shows that lactate administration induced an
increase in phosphorylated AktThr308 in Quad (2.0-fold;
P = 0.02) and EDL (2.2-fold; P = 0.02). There was a
nonsignificant tendency toward an increase in Sol (1.7-
fold; P = 0.06). Phosphorylation of AktSer473 (Fig. 2D)
increased only in Quad (2.4-fold; P = 0.01). EDL muscle
showed a nonsignificant tendency toward an increase
(1.8-fold; P = 0.07).
We next investigated commonly used markers of
mTORC1 signaling including p70S6KThr389 and rpS6Ser235/
236 (Ogasawara et al. 2016). Fig 3E shows that phosphory-
lation of p70S6KThr389 was increased by lactate
administration only in Quad (1.9-fold; P = 0.01). Lactate
administration increased p-rpS6Ser235/236 (Fig. 2F) in
Quad (6.3-fold; P = 0.01) and EDL (2.3-fold; P = 0.01).
There were no changes in Sol.
AMPK controls the expression of oxidative metabo-
lism-related genes and also regulates metabolism dur-
ing exercise (Fritzen et al. 2015; Kjøbsted et al. 2018;
McGee and Hargreaves 2010). We tested whether
in vivo lactate administration activates the AMPK
pathway. Figure 3A shows that lactate injection
induced a nonsignificant increase in p-AMPKThr172 in
Sol (1.7-fold; P = 0.08), without changes in Quad and
EDL. Phosphorylation of ACCSer79 only increased in
Sol (1.5-fold; P = 0.04; Fig. 3B). There were no
changes in phosphorylation of TBC1D1Ser237 in any
muscle (Fig. 3C). Intriguingly, we only found an
increase in phosphorylation of TBC1D4Thr642 in Sol
(1.5-fold; P = 0.04, Fig. 3D), without changes in Quad
and EDL.
AMPK regulates PDH activity and fuel selection in
muscle metabolism (Fritzen et al. 2015). Therefore, we
assessed PDH phosphorylation on the E1a subunit as a
marker of its activity (Klein et al. 2007). Phosphorylation
of PDH-E1aSer300 decreased only in Sol (0.6-fold;
P = 0.004; Fig.3F), but not in Quad and EDL muscles.
Moreover, phosphorylation of PDH-E1aSer293 (Fig. 3E)
showed a nonsignificant tendency toward a decrease in
Sol (0.6-fold; P = 0.1) and a nonsignificant increase in
Quad (1.4-fold; P = 0.1).
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Figure 1. Lactate administration increases blood lactate levels
without changes in blood glucose and insulin levels. Blood lactate
(A), glucose (B), and insulin (C) levels after intraperitoneal injection
of vehicle (VEH, n = 3–5, gray line) or lactate (LAC, n = 5–7, black
line). The data are presented as the median and interquartile range.
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Figure 3. Lactate administration increases intracellular signaling related to AMPK pathway. Phosphorylation of AMPKThr172 (A), ACCSer79 (B),
TBC1D1Ser237 (C), TBC1D4Thr642 (D), PDH-E1aSer293 (E), and PDH-E1aSer300 (F) in quadriceps (Quad), extensor digitorum longus (EDL), and soleus
(Sol) skeletal muscles after vehicle (VEH, n = 5) or lactate (LAC, n = 7) administration. Bars represent the median in the scatterplot.
Representative immunoblots are shown in G. VEH, vehicle; LAC, lactate. Values in graphs are arbitrary units (A.U.). Statistical significance
compared with vehicle is indicated by *P < 0.05 and **P < 0.01. d: effect size with 95% confidence interval.
2018 | Vol. 6 | Iss. 18 | e13800
Page 6
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Lactate and Signaling Pathways In Skeletal Muscle H. Cerda-Kohler et al.
Discussion
This study showed for the first time that lactate in vivo
administration activates intracellular signaling pathways in
mature skeletal muscle. Our main finding was that in vivo
lactate administration increased protein phosphorylation
related to the ERK1/2, Akt/mTORC1, and AMPK path-
ways differentially depending on the skeletal muscle type.
Recent studies have shown that lactate activates the
ERK1/2 pathway and regulates myogenesis (Willkomm
et al. 2014), stimulates the anabolic signals regulating
hypertrophy (Oishi et al. 2015), and increases myotube
diameter (Ohno et al. 2018) in skeletal muscle cell lines.
Here, we demonstrated that phosphorylation of ERK1/
2Thr202/Tyr204 and p70S6KThr389 was significantly increased
in Quad, while phosphorylation of AktThr308, AktSer473,
and rpS6Ser235/236 was significantly increased in both Quad
and EDL, without significant changes in Sol muscle.
These results are consistent with previous studies in
C2C12 myotubes that show an increase in p-ERK1/
2Thr202/Tyr204 after incubation of 20 mmol/L lactate for
2 h (Ohno et al. 2018), and an increase in p-p70S6KThr389
after incubation of 10 mmol/L lactate for 6 h (Oishi et al.
2015). Taken together, these findings showed that in vivo
lactate administration is sufficient to activate proteins
related to ERK1/2 and Akt/mTORC1 pathways. The
results suggest that lactate is involved in the signaling net-
work related with protein synthesis in skeletal muscle,
preferentially (if not exclusively) in mixed/glycolytic adult
skeletal muscles type as Quad and EDL (Fig. 4A), but not
in oxidative muscles as Sol.
Lactate increases mRNA levels of genes related to
oxidative metabolism in L6 myotubes (Hashimoto et al.
2007) and mature skeletal muscle (Kitaoka et al. 2016).
AMPK activation enhances muscle fiber oxidative meta-
bolism by stimulating mitochondrial biogenesis (Kjøbsted
et al. 2018). Interestingly, Hoshino and colleagues (Hos-
hino et al. 2015) showed that prior administration of
dichloroacetate decreased lactate accumulation in blood
and muscle during exercise which tended to decrease
phosphorylation of AMPKThr172, suggesting a role of lac-
tate in AMPK activation in skeletal muscle. In this study,
we found that lactate stimulation trended toward increas-
ing the phosphorylation of AMPKThr172 and significantly
increased ACCSer79 in Sol, without changes in Quad and
EDL. Interestingly, in soleus we found an increase in the
phosphorylation of TBC1D4Thr642, without changes in
p-TBC1D1Ser237. Since p-TBD1D4Thr642 is not a substrate
of AMPK (Kjøbsted et al. 2018), these results suggest an
alternative mechanism for regulation of this protein.
Recently, Fritzen and colleagues demonstrated that
AMPKa2 regulates muscle metabolism through inhibition
of the PDH complex (Fritzen et al. 2015). Here, we
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Figure 4. Lactate-induced hypertrophic and oxidative signaling
pathways activation in skeletal muscle. The working hypothesis for
signaling pathways activated by in vivo lactate administration in
mixed/fast (A) and slow (B) skeletal muscles. ERK1/2: extracellular
signal-regulated protein kinases 1 and 2; Akt: protein kinase B;
TSC2: tuberous sclerosis complex 2; mTORC1: mammalian target of
rapamycin complex 1; p70S6K: ribosomal S6 kinase; rpS6:
ribosomal protein S6; AMPK: 5’-AMP-activated protein kinase;
TBC1D4: TBC1 domain family member 4; ACC: Acetyl-CoA
carboxylase; PDH: pyruvate dehydrogenase. ? represents
activation; I represents inhibition. +P: increased phosphorylation; -
P: decreased phosphorylation. ? represents unknown mechanisms.
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observed a significant decrease in p-PDH-E1aSer300 in Sol,
a tendency toward a decrease in EDL, without changes in
Quad, suggesting that indeed this pathway could be regu-
lated this way. We found no changes in phosphorylation
of PDH-E1aSer293 in any muscle. Collectively, these results
showed that in vivo lactate administration activated
AMPK and downstream targets mainly in oxidative skele-
tal muscle type as Sol, supporting the hypothesis that lac-
tate may be involved in the signaling network related
with the oxidative metabolism (Fig. 4B).
In summary, our results support the hypothesis that
lactate plays a role in the activation of signaling pathways
related to hypertrophy in mixed/fast muscles via Akt/
mTORC1 and ERK1/2 and that it also plays a role in reg-
ulating oxidative metabolism via AMPK in slow adult
skeletal muscle. Our results suggest that, due to the differ-
ential effect of lactate administration in different muscle
types, lactate signaling could be reinforcing the muscle
phenotype after exercise. Our study highlights the rele-
vance of understanding how lactate mediates the molecu-
lar signaling on skeletal muscles, and we cannot rule out
the existence of interorgan crosstalk. The mechanisms
that underlie the effect of lactate in mature skeletal mus-
cles remain to be established.
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